Tracheostomy, Prolonged Mechanical Ventilation, Tracheostomy Decannulation
Conditions
Keywords
tracheostomy decannulation, capping trial, instrumental dead space, esophageal pressure, critical illness
Brief summary
Some critically ill patients need a breathing tube placed directly into the windpipe (tracheostomy) because they require long-term help from a breathing machine. Before this tube can be safely removed (decannulation), medical team need to confirm the patient is ready to breathe on their own through the nose and mouth again. The most common way to check this is a "capping trial," in which the tube is blocked so air must pass through the upper airway, similar to normal breathing. However, because the tube itself remains in place during this test, it narrows the airway and may make breathing harder than it would be if the tube were actually removed. This could cause some patients to fail the test even though they are truly ready for the tube to come out, leading to unnecessary delays. This study will compare the standard capping trial with a new approach that instead adds extra tubing (dead space) to the breathing circuit, without blocking the airway, to more closely copy the breathing effort patients will experience once the tube is removed. Each participant will undergo both methods, in random order, during a single study day, with breathing effort, muscle activity, and comfort measured during each method and again after the tube is actually removed. The goal is to determine which method more accurately predicts how a patient will actually breathe once the tracheostomy tube is taken out.
Detailed description
Approximately 10-15% of mechanically ventilated intensive care unit (ICU) patients require prolonged mechanical ventilation, and tracheostomy is frequently used to facilitate weaning and respiratory rehabilitation in this population. Tracheostomy decannulation is a key recovery milestone, but there is no standardized method for confirming readiness. The tracheostomy capping trial, in which the tube is occluded to redirect airflow through the upper airway, is the most widely used final assessment prior to decannulation; however, because the tracheostomy tube remains in place, it substantially narrows the airway lumen and may increase airflow resistance up to 16-fold compared to true post-decannulation breathing (per Poiseuille's law). This supraphysiological load may cause capping trial failure in patients who would otherwise tolerate decannulation, particularly those with pre-existing respiratory muscle weakness related to ICU-acquired weakness, which affects up to 80% of patients requiring prolonged mechanical ventilation. Preliminary physiological data from the investigators' group (unpublished) demonstrated that the esophageal pressure-time product (PTP), a validated marker of the work of breathing, increased by 226% during capping trials compared to baseline, then decreased after actual decannulation to levels close to baseline, suggesting the capping trial substantially overestimates the respiratory burden that patients will face after tube removal. This study proposes an alternative physiological assessment using incremental instrumental dead space, which reproduces the anatomical dead space increase that occurs after decannulation without imposing the artificial airway resistance created by the tracheostomy tube during capping. In a randomized crossover design, each participant will undergo both the capping trial and the incremental dead space strategy in random order, followed by assessment after actual decannulation, allowing within-participant comparison of which method better predicts the true post-decannulation respiratory status.
Interventions
Instrumental dead space applied through a modular low-resistance circuit connected to the tracheostomy for 45 minutes, intended to reproduce the respiratory demand associated with restoration of the upper airway after decannulation.
The tracheostomy cuff is deflated and the tube is completely occluded with a standard cap, requiring the participant to breathe through the upper airway for 45 minutes unless predefined intolerance or safety criteria require earlier discontinuation.
Sponsors
Study design
Masking description
Blinding of participants and bedside investigators is not feasible because the interventions are visibly different. Physiological signal analysis will be performed offline with the analysis blinded to the randomization sequence whenever feasible.
Intervention model description
Each participant is randomized to one of two sequences and receives both study conditions (incremental instrumental dead space and capping trial) in the assigned order, separated by a 20-minute washout period breathing spontaneously through an open T-piece connected to the tracheostomy, followed by assessment after actual tracheostomy decannulation.
Eligibility
Inclusion criteria
* Adult patients (≥18 years) admitted to the ICU. * Presence of a tracheostomy due to prolonged mechanical ventilation (≥14 days). * Clinically considered ready for decannulation, according to institutional criteria (e.g., stable gas exchange, minimal secretions, effective cough, and tolerance to spontaneous breathing). * Ability to maintain spontaneous breathing without mechanical ventilation for more than 48 consecutive hours. * Able to cooperate and follow basic commands (RASS between -1 and +1). * Written informed consent obtained from patient.
Exclusion criteria
* Neuromuscular disease affecting respiratory muscles (e.g., myasthenia gravis, Guillain-Barre syndrome, amyotrophic lateral sclerosis). * Hemodynamic instability. * Severe agitation or delirium precluding cooperation (RASS \< -2 or \> +2). * Structural airway abnormalities (e.g., subglottic stenosis, tracheomalacia). * Pregnancy. * Contraindications for esophageal balloon catheter insertion (e.g., severe coagulopathy, esophageal varices, and history of esophageal or gastric surgery). * Refusal to participate by the attending physician.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Within-Participant Absolute Error in Pressure-Time Product Post-Decannulation Breathing | During the final 10 minutes of each 45-minute pre-decannulation condition and during the post-decannulation assessment | Respiratory effort will be quantified using the esophageal pressure-time product per breath (PTP), calculated from the esophageal pressure signal. For each pre-decannulation strategy, predictive accuracy will be quantified as the absolute within-participant difference between PTP measured during that strategy and PTP measured during post-decannulation spontaneous breathing. The primary comparison will assess whether the absolute error is lower during incremental instrumental dead space than during the capping trial. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Accessory Respiratory Muscle Surface Electromyography Activity | Final 10 minutes of each 45-minute study condition and post-decannulation assessment | Surface electromyography will quantify respiratory muscle recruitment in the sternocleidomastoid, intercostal/parasternal, and abdominal muscles. Signal amplitude and prespecified frequency-domain characteristics will be analyzed offline according to the final signal-processing plan. |
| Perceived Dyspnea / Respiratory Discomfort | Beginning and end of each 45-minute study condition and when clinically indicated | Participant-reported respiratory discomfort assessed using the modified Borg scale from 0 to 10. |
| Esophageal Pressure Swing (ΔPes) | Final 10 minutes of each 45-minute study condition and post-decannulation assessment | Mean inspiratory esophageal pressure swing measured from the esophageal pressure signal as an index of inspiratory effort. |
| Pressure-Time Product per Minute (PTPmin) | Final 10 minutes of each 45-minute study condition and post-decannulation assessment | Pressure-time product per minute, calculated from the esophageal pressure signal by integrating the per-breath pressure-time product over one minute of recording. |
Countries
Chile